Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business Sort descending
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Sort descending Area funzionale Data di pubblicazione
MR Changsha (Hunan Province) Cina International Innovative Medicines I saldi Ott 17, 2024
AD, Access & Reimbursement - Minneapolis - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 17, 2024
Associate Director, Access & Reimbursement RLT - San Diego, CA - Remote Field Non-Sales (USA) USA US Innovative Medicines Market Access Ott 17, 2024
Global Program Safety Lead - Immunology Basel (City) Svizzera Development Innovative Medicines Research & Development Ott 17, 2024
Strategy Director, Clinical Development Basel (City) Svizzera Development Innovative Medicines Research & Development Ott 17, 2024
Patient Support - Manager, Program Operations Management East Hanover USA US Innovative Medicines Marketing Ott 17, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Messico International Innovative Medicines Marketing Ott 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Rocky Mountains - Remote Field Non-Sales (USA) USA US Innovative Medicines I saldi Ott 17, 2024
Associate Director, Integrated Insights, New Products, Oncology East Hanover USA US Innovative Medicines Marketing Ott 17, 2024
Medical Science Liaison (MSL) ONC Solid Tumor Chicago Territory Remote Field Non-Sales (USA) USA US Innovative Medicines Research & Development Ott 17, 2024
Access & Reimbursement Manager NPS - Enterprise - Great Lakes - Remote Field Non-Sales (USA) USA US Innovative Medicines I saldi Ott 17, 2024
Pros Business Leader - Mountain West Field Sales (USA) USA US Innovative Medicines I saldi Ott 17, 2024
Senior Clinical Research Associate (Remote) Field Non-Sales (USA) USA Development Innovative Medicines Research & Development Ott 17, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) Cina International Innovative Medicines I saldi Ott 17, 2024
(高级)大区经理 Shanghai (Shanghai) Cina International Innovative Medicines I saldi Ott 17, 2024
Medical Representative - Cardiovascular Makati City Filippine International Innovative Medicines I saldi Ott 17, 2024
Digital Quality Control specialist INSURGENTES Messico Operations Innovative Medicines Quality Ott 17, 2024
Compliance & Quality System Manager Ivrea Italia Operations Innovative Medicines Quality Ott 17, 2024
Produktionsmitarbeiter (m/f/d), Kundl, Tirol, Austria Kundl Austria Operations Innovative Medicines Technical Operations Ott 18, 2024
Medical Advisor, Ophtha Shanghai (Shanghai) Cina International Innovative Medicines Research & Development Ott 18, 2024
Medical Advisor, HEMA Shanghai (Shanghai) Cina International Innovative Medicines Research & Development Ott 18, 2024
Produktionsmitarbeiter (m/w/d), Schaftenau, Tirol, Austria Schaftenau Austria Operations Innovative Medicines Technical Operations Ott 18, 2024
Production Technician - CDD / SCL Saint-Cloud Francia Operations Innovative Medicines Technical Operations Ott 18, 2024
Data Analyst, Digital Finance Hyderabad (Office) India Operations Innovative Medicines Audit e finanza Ott 18, 2024
Senior Principal Clinical Data Standards Specialist Mumbai (Office) India Development Innovative Medicines Research & Development Ott 18, 2024
Quality Control Staff Sasayama Giappone Operations Innovative Medicines Quality Ott 18, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Lug 10, 2024
DM Fuzhou (Fujian Province) Cina International Innovative Medicines I saldi Lug 18, 2024
Senior Statistical Programmer Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Lug 18, 2024
QC Analyst Sasayama Giappone Operations Innovative Medicines Quality Set 03, 2024
MR Shenzhen (Guangdong Province) Cina International Innovative Medicines I saldi Lug 22, 2024
Associate/Manager, MSL(Oncology) Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Lug 22, 2024
Product Specialist Fuzhou (Fujian Province) Cina International Innovative Medicines I saldi Lug 23, 2024
MR Wuhan (Hubei Province) Cina International Innovative Medicines I saldi Lug 28, 2024
County Executive Xiaogan (Hubei Province) Cina International Innovative Medicines I saldi Lug 28, 2024
Senior MR Guangzhou (Guangdong Province) Cina International Innovative Medicines I saldi Lug 30, 2024
Solution Design Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Set 03, 2024
MR Fuyang (Anhui Province) Cina International Innovative Medicines I saldi Ago 05, 2024
Senior/Advanced Medical/Sales Representative Beijing (Beijing) Cina International Innovative Medicines I saldi Ago 06, 2024
Product Specialist Jingzhou (Hubei Province) Cina International Innovative Medicines I saldi Ago 06, 2024
Associate/Manager, MSL (Cardiovascular) Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Ago 20, 2024
Medical Field Trainer Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Ago 29, 2024
(高级)医药代表 /(资深)产品专员 Xianyang (Shanxi Province) Cina International Innovative Medicines I saldi Ago 30, 2024
MR Beijing (Beijing) Cina International Innovative Medicines I saldi Set 01, 2024
Study Leader Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Set 05, 2024
Group Manager, MSL Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Set 05, 2024
县域主任/县域主管 Yibin (Sichuan Province) Cina International Innovative Medicines I saldi Set 10, 2024
Japan Program Clinical Head (IMM) Head Office (Japan) (Pharmaceuticals) Giappone Biomedical Research Innovative Medicines Research & Development Set 10, 2024
Lead/Associate, CX Content Creation Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Marketing Set 17, 2024
MR Pingxiang (Jiangxi Province) Cina International Innovative Medicines I saldi Set 23, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia